SCHEMBL2866334

SCHEMBL2866334

[2H]C(=O)C([2H])([2H])OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
IDO1 P14902 1/20 0.40
AGXT P21549 1/20 0.39
CCNB2 O95067 1/20 0.39
CDK1 P06493 1/20 0.39
CDK4 P11802 1/20 0.39
CCNB1 P14635 1/20 0.39
CCND1 P24385 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA9 Q16790 3/20 0.38
ALDH1A1 P00352 3/20 0.38
CA7 P43166 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12223226 0.86 TSHR (0.56) TSHRIDO1AGXTCCNB2CDK1
SCHEMBL2532264 0.84 TSHR (0.54) TSHRIDO1AGXTCCNB2CDK1
SCHEMBL30929702 0.82 TSHR (0.56) TSHRIDO1AGXTCCNB2CDK1
SCHEMBL30425720 0.72 TSHR (0.61) TSHRIDO1AGXTCCNB2CDK1
SCHEMBL76044 0.72 TSHR (0.61) TSHRIDO1AGXTCCNB2CDK1
SCHEMBL27380 0.72 TSHR (1.00) TSHRIDO1AGXTCA1CA2
SCHEMBL5311581 0.72 TSHR (1.00) TSHRIDO1AGXTCA1CA2
Benzene SCHEMBL27997624 0.72 TSHR (1.00) TSHRIDO1AGXTCA1CA2
SCHEMBL22160794 0.71 TSHR (0.58) TSHRIDO1AGXTCCNB2CDK1
Propionaldehyde SCHEMBL9514587 0.71 TSHR (0.65) TSHRIDO1AGXTCCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115304460-A Synthesis method of decanal-1,2,2,3,3-d 5 深圳鼎邦生物科技有限公司 2022-11-08 CN disclosed
US-20100305173-A1 HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES CONCERT PHARMACEUTICALS, INC. (US) 2010-12-02 US disclosed
US-20100305173-A1 HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES CONCERT PHARMACEUTICALS, INC. (US) 2010-12-02 US disclosed
US-20100113589-A1 Deuterated darunavir CONCERT PHARMACCUTICALS, INC. (US) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305173-A1 HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES STS, PRSS1, PRSS3 TSHR 4797/4885IDO1 1459/4885AGXT 752/4885
US-20100113589-A1 Deuterated darunavir SAMHD1, DUT, DNPEP TSHR 4215/4885IDO1 1893/4885AGXT 891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.